Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir DF in HIV-1 Infected Adolescents
NCT00352053Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Jun 2006; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00352053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352053.